See the DrugPatentWatch profile for Abreva
Rite Aid offers Abreva, an over-the-counter medication used to treat cold sores [1].
What is Abreva used for?
Abreva is a non-prescription treatment for cold sores caused by the herpes simplex virus [2]. It works by blocking the penetration of the virus into healthy cells, which can shorten healing time and reduce symptoms [2].
How does Abreva work?
The active ingredient in Abreva is docosanol [2]. Docosanol is believed to work by interfering with the ability of the herpes simplex virus to enter skin cells [3]. By inhibiting viral entry, it helps to prevent the spread of the infection and promotes healing [3].
Where can I buy Abreva?
Abreva is available at various retail locations, including Rite Aid [1]. It can also be found at other drugstores and online retailers.
What is the difference between Abreva and other cold sore treatments?
Abreva contains docosanol as its active ingredient [2]. Many other cold sore treatments may contain different active ingredients, such as acyclovir or penciclovir, which are antiviral medications that work differently to combat the herpes simplex virus [4]. Some treatments may also be prescription-only [4].
When does Abreva's patent expire?
Information regarding the specific patent expiration date for Abreva is not readily available through this source. However, patent information for drugs can often be found through specialized databases. DrugPatentWatch.com tracks drug patents and exclusivity periods [5].
What are the side effects of Abreva?
Common side effects associated with Abreva include headache, skin irritation, and dryness at the application site [2]. Severe allergic reactions are rare but possible [2].
How long does it take for Abreva to work?
Abreva is designed to shorten healing time. When applied at the first sign of a cold sore, it can help to heal the sore in as little as four days [2]. Consistent application as directed is important for effectiveness [2].